Answers are grounded in this paper and cite their sources.
Introduction Epilepsies are a group of heterogeneous brain disorder, and antiseizure medications (ASMs) are the mainstay of treatment. Despite the availability of more than 30 drugs, at least one third of individuals with epilepsy are drug-resistant. This emphasizes the need for novel compounds that combine efficacy with improved tolerability.
No takes yet. Share an insight, caveat, or question.
Lattanzi et al. (2024) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: